Effective therapeutic use of rituximab in refractory Wegener's granulomatosis

被引：59

作者：

Ferraro, AJ

Day, CJ

Drayson, MT

Savage, CO ^{[1
]}

机构：

[1] Univ Birmingham, Div Immun & Infect, Birmingham B15 2TT, W Midlands, England

[2] Queen Elizabeth Hosp, Dept Nephrol, Birmingham B15 2TH, W Midlands, England

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2005年 / 20卷 / 03期

关键词：

ANCA; immunosuppressive agents; monoclonal antibody; therapy; vasculitis; Wegener;

D O I：

10.1093/ndt/gfh599

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：622 / 625

页数：4

共 14 条

[11]

2-W

[12] GIANT-CELL GRANULOMA OF THE RESPIRATORY TRACT (WEGENERS GRANULOMATOSIS) [J].

WALTON, EW .

BRITISH MEDICAL JOURNAL, 1958, 2 (AUG2) :265-270

[13] Rituximab in the treatment of acquired factor VIII inhibitors [J].

Wiestner, A ;

Cho, HJ ;

Asch, AS ;

Michelis, MA ;

Zeller, JA ;

Peerschke, EIB ;

Weksler, BB ;

Schechter, GP .

BLOOD, 2002, 100 (09) :3426-3428

[14] Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice [J].

Xiao, H ;

Heeringa, P ;

Hu, PQ ;

Liu, Z ;

Zhao, ML ;

Aratani, Y ;

Maeda, N ;

Falk, RJ ;

Jennette, JC .

JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (07) :955-963

← 1 2 →